DNA Sequencing Leader Illumina Eyes Its Next Move: Distributed Diagnostics

Investors have seen no shortage of big watershed moments from DNA sequencing pioneer Illumina in recent years. The company's announcements of its refrigerator-sized human genome sequencing machines and its symbolic $1,000 human genome have grabbed the attention of observers and investors alike...